A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802

Sarcomatoid features can arise in renal cell carcinoma of any subtype and are associated with a poor prognosis. Doxorubicin and gemcitabine in a limited series showed activity in aggressive renal tumors and we wished to formally assess the combination in patients with renal cell carcinoma specifical...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Haas, Naomi B., Lin, Xinyi, Manola, Judith, Pins, Michael, Liu, Glenn, McDermott, David, Nanus, David, Heath, Elisabeth, Wilding, George, Dutcher, Janice
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566570/
https://ncbi.nlm.nih.gov/pubmed/21298497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-011-9829-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares